We know the good results from Mayo clinic phase II trial of EGCG on CLL patients. However, the trial finished in 6 months, so we do not know the results after the trial finished. I hear that some people continued to take EGCG after trial finished. I wish to ask someone attend this trial whether or not CLL progression remains to stop or go slowly when continued to take EGCG more than 6 months. Also I am afraid that strong rebound (progression enhanced) occur when stop taking EGCG . This is my experience, and also described in paper on the phase II trial. I appreciate if someone might give us information.
Plot shows probable effect of ~2 grams per day of EGCG on ALT liver function blood test counts, followed by EGCG dose reduction. Dotted red line is upper reference range. AST showed a similar spike of 70% above average to just under the upper reference range, which also recovered. If you take EGCG you should have your ALT and AST liver function counts monitored regularly - Admin